Jones Day hosted a webinar series discussing pertinent topics in the life sciences industry. This six-part series will focus on cybersecurity and data privacy, IP, corporate, antitrust, tax, and health care regulatory topics for pharma, biotech, medtech, and digital health companies around the world.
SESSION I: Cybersecurity, Privacy, and Data Protection: Cybersecurity and Privacy Developments for Life Sciences Companies
The following topics will be examined in this session on cybersecurity and privacy developments in the life sciences:
- International transfer developments.
- Trends in enforcement (GDPR and U.S. litigation).
- Emerging privacy laws and policy that affect life sciences clients (e.g., the U.S. ADPPA; the proposed rule for modernizing HIPAA; and state laws (CA, NY)).
- Limits on data commercialization.
- The EU health data legal framework: What is to come?
Presenters: Dr. Jörg Hladjk, Mauricio F. Paez
SESSION II: Intellectual Property: Collaborating and Commercializing: Key IP Considerations for Life Sciences Companies
This session will explore issues that frequently arise in the negotiation, implementation, and litigation of collaboration and commercialization agreements in the life sciences sector. Specific topics will include:
- The most common ways IP disputes arise between parties to these agreements.
- Drafting and negotiation strategies for mitigating litigation.
- Dispute resolution options and best practices.
- Preparing global IP portfolios for litigation and diligences.
Presenters: Jeremy P. Cole, Sarah A. Geers, Ka-on Li, Bing Liang, Ph.D.
SESSION III: Capital Markets: Preparing Your Life Sciences Company for an IPO
In this session, which will discuss preparing life sciences companies for IPOs, the following topics will be addressed:
- The state of the market.
- Preparing your IPO road map:
- Key attributes of an IPO-ready company.
- Key stages of the process.
- A typical timeline.
- Consideration of potential listing jurisdictions.
- Practical tips for a successful IPO.
- Crossover financings.
- Corporate life after the IPO.
Presenters: Renaud Bonnet, Charles Chau, Peter E. Devlin, Giles P. Elliott, Vica Irani, Ferrell M. Keel,
SESSION IV: Tax: Taxes in Collaboration Agreements in the Life Sciences Industry
In this session, we will discuss the payments that are commonly due under license and collaboration agreements in the pharmaceutical industry, how such payments are taxed, and the provisions in such agreements that allocate tax payment responsibility between payor and payee.
Presenters: Thomas A. Briggs, Christopher S. Hanfling, Edward T. Kennedy
SESSION V: Health Care Regulatory: Trends and Issues in Enforcement and Whistleblower Claims
The specific topics that will be discussed in this session reviewing the trends and issues in enforcement and whistleblower claims include the following:
- The regulatory landscape.
- General readiness.
- Enhanced risk – convergence of payor/providers.
Presenters: Heather O'Shea, Cristiana Spontoni, Kyle A. Diamantas
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.